Voya Investment Management LLC Immunity Bio, Inc. Transaction History

Voya Investment Management LLC

$82.2 Billion
Q2 2025

A detailed history of Voya Investment Management LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 62,957 shares of IBRX stock, worth $155,503. This represents 0.0% of its overall portfolio holdings.

Number of Shares

62,957

Previous 39,451 59.58%

Holding current value

$155,503

Previous $118,000 40.68%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$1.89 - $3.44 $44,426 - $80,860	23,506 Added 59.58%	62,957 $166,000
Q1 2025 May 15, 2025	SELL	$2.32 - $3.9 $10,562 - $17,756	-4,553 Reduced 10.35%	39,451 $118,000
Q4 2024 Feb 14, 2025	SELL	$2.56 - $6.17 $6,584 - $15,869	-2,572 Reduced 5.52%	44,004 $112,000
Q3 2024 Feb 07, 2025	SELL	$3.32 - $6.7 $444,461 - $896,955	-133,874 Reduced 74.19%	46,576 $172,000
Q3 2024 Nov 14, 2024	SELL	$3.32 - $6.7 $444,461 - $896,955	-133,874 Reduced 74.19%	46,576 $172,000
Q2 2024 Feb 07, 2025	BUY	$4.82 - $9.15 $658,681 - $1.25 Million	136,656 Added 312.04%	180,450 $1.14 Million
Q2 2024 Dec 03, 2024	BUY	$4.82 - $9.15 $645,272 - $1.22 Million	133,874 Added 287.43%	180,450 $1.14 Million
Q2 2024 Aug 14, 2024	BUY	$4.82 - $9.15 $658,681 - $1.25 Million	136,656 Added 312.04%	180,450 $1.14 Million
Q1 2024 Feb 07, 2025	SELL	$3.23 - $6.17 $8,985 - $17,164	-2,782 Reduced 5.97%	43,794 $235,000
Q1 2024 Dec 06, 2024	SELL	$3.23 - $6.17 $8,985 - $17,164	-2,782 Reduced 5.97%	43,794 $235,000
Q1 2024 May 15, 2024	SELL	$3.23 - $6.17 $29,935 - $57,183	-9,268 Reduced 17.47%	43,794 $235,000
Q4 2023 Feb 07, 2025	BUY	$1.25 - $5.21 $8,841 - $36,850	7,073 Added 15.38%	53,062 $266,000
Q4 2023 Feb 14, 2024	BUY	$1.25 - $5.21 $8,841 - $36,850	7,073 Added 15.38%	53,062 $266,000
Q3 2023 Feb 07, 2025	BUY	$1.29 - $3.1 $3,034 - $7,291	2,352 Added 5.39%	45,989 $77,000
Q3 2023 Nov 14, 2023	BUY	$1.29 - $3.1 $3,034 - $7,291	2,352 Added 5.39%	45,989 $77,000
Q2 2023 Feb 07, 2025	BUY	$1.53 - $6.41 $18,698 - $78,336	12,221 Added 38.9%	43,637 $121,000
Q2 2023 Aug 14, 2023	BUY	$1.53 - $6.41 $18,698 - $78,336	12,221 Added 38.9%	43,637 $121,000
Q1 2023 Feb 07, 2025	SELL	$1.35 - $4.78 $20,466 - $72,464	-15,160 Reduced 32.55%	31,416 $57,000
Q3 2022 Feb 07, 2025	SELL	$3.65 - $6.43 $55,334 - $97,478	-15,160 Reduced 32.55%	31,416 $156,000
Q2 2022 Aug 15, 2022	BUY	$2.68 - $6.14 $13,834 - $31,694	5,162 Added 19.66%	31,416 $117,000
Q4 2021 Feb 14, 2022	SELL	$5.67 - $10.18 $1,230 - $2,209	-217 Reduced 0.82%	26,254 $160,000
Q2 2021 Aug 16, 2021	BUY	$13.41 - $22.4 $169,663 - $283,404	12,652 Added 91.56%	26,471 $378,000
Q1 2021 May 17, 2021	BUY	$12.83 - $42.25 $177,297 - $583,852	13,819 New	13,819 $328,000

Others Institutions Holding IBRX

# of Institutions

274

Shares Held

120M

Call Options Held

2.47M

Put Options Held

3.13M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $989M
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account

Voya Investment Management LLC Immunity Bio, Inc. Transaction History